NCT06966947

Brief Summary

This clinical study aims to evaluate the effectiveness of a perioperative risk early warning management strategy in patients undergoing surgical treatment for hip fractures. Hip fractures are common in elderly individuals and are associated with a high risk of postoperative complications. Traditional perioperative care may not sufficiently identify and respond to early signs of clinical deterioration. In this study, patients with hip fractures admitted to the orthopedic department of a single hospital from January 2023 to December 2023 were divided into two groups based on their admission time. Patients admitted between June and December 2023 received the early warning risk management intervention (experimental group), while those admitted between January and May 2023 received routine perioperative care (control group). The early warning management system involved a scoring-based approach using vital signs such as heart rate, respiratory rate, blood pressure, body temperature, and consciousness level to classify patients' risk levels. Nursing staff responded with graded interventions, including enhanced monitoring and rapid physician notification for higher-risk patients. The study retrospectively enrolled 284 patients in total, with 142 in each group. The primary outcomes include changes in coagulation function, self-care ability (measured by the Exercise of Self-care Agency Scale, ESCA), and hip joint functional recovery (measured by the Hospital for Special Surgery, HSS, score). Secondary outcomes include patient satisfaction and incidence of postoperative complications. The central hypothesis is that perioperative risk early warning management will improve patient safety, enhance self-care capacity, reduce complications, and promote better recovery outcomes compared to routine care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
284

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 13, 2025

Completed
Last Updated

May 13, 2025

Status Verified

May 1, 2025

Enrollment Period

12 months

First QC Date

April 9, 2025

Last Update Submit

May 11, 2025

Conditions

Keywords

Risk early warning managementHip fracture rehabilitationPostoperative delirium preventionProximal femoral nail (PFN) surgeryElderly orthopedic patientsBlood coagulation functionSelf-care abilityRetrospective cohort study

Outcome Measures

Primary Outcomes (4)

  • Change in Prothrombin Time (PT)

    Prothrombin Time (PT) will be measured in seconds using a standardized coagulation analyzer to evaluate the extrinsic coagulation pathway. Preoperative and postoperative PT values will be compared between the intervention and control groups.

    Preoperative baseline and Postoperative 3 days

  • Change in Activated Partial Thromboplastin Time (APTT)

    Activated Partial Thromboplastin Time (APTT) will be measured in seconds to assess the intrinsic coagulation pathway. Preoperative and postoperative APTT values will be compared between groups.

    Preoperative baseline and Postoperative 3 days

  • Change in Fibrinogen (FBG) Levels

    Fibrinogen levels (g/L) will be quantified to reflect clotting factor concentration. Preoperative and postoperative FBG values will be compared between groups.

    Preoperative baseline and Postoperative 3 days

  • Change in D-Dimer (D-D) Levels

    D-dimer levels (mg/L) will be measured to evaluate fibrinolysis activity. Preoperative and postoperative D-D values will be compared between groups.

    Preoperative baseline and Postoperative 3 days

Secondary Outcomes (3)

  • Change in Exercise of Self-Care Agency Scale (ESCA) Score

    Baseline (pre-intervention) and immediately after the intervention

  • Incidence of Postoperative Complications

    Perioperative period to 30 days after Endpoint (day of discharge)

  • Patient Satisfaction Rate

    Immediately after the intervention

Study Arms (2)

Risk Early Warning Perioperative Management

Participants in this arm received a structured risk early warning management intervention during the perioperative period. The intervention included the establishment of a dedicated nursing team, systematic evaluation of vital signs (heart rate, respiratory rate, blood pressure, temperature, and consciousness), and scoring of patient condition based on a predefined risk assessment table. Based on the risk score, patients received tiered monitoring and intervention: Score 0-4: Routine care and monitoring Score 5-7 or single item score = 3: Intensive monitoring every 4 hours and physician notification Score ≥7: Continuous monitoring, immediate physician arrival, and bedside emergency preparedness This strategy aimed to detect and respond to patient deterioration early, thereby reducing complications and improving recovery outcomes.

Behavioral: Risk Early Warning Management

Routine Perioperative Management

Participants in this arm received standard perioperative care according to hospital guidelines. This included general health education prior to surgery, assistance during the perioperative period, routine postoperative care such as anticoagulation and infection prevention, regular vital signs monitoring, and standard nursing interventions. No specific early warning risk scoring or tiered response strategy was implemented.

Behavioral: Standard Perioperative Care

Interventions

This intervention involves a perioperative risk early warning management strategy for hip fracture patients. A dedicated team of nurses is responsible for monitoring vital signs (heart rate, blood pressure, respiratory rate, temperature, and consciousness level) to identify and respond to early signs of clinical deterioration. The intervention follows a structured scoring system that classifies patients into different risk levels based on their vital signs: Risk Score 0-4: Standard perioperative care and monitoring Risk Score 5-7 (or single-item score ≥3): Intensive monitoring with vital sign checks every 4 hours and immediate physician notification if condition changes Risk Score ≥7: Continuous monitoring, with immediate physician availability and ready access to emergency equipment The intervention aims to improve patient outcomes by ensuring early identification of deterioration and more rapid response to clinical changes. A red warning sign will also be placed at the patient's b

Risk Early Warning Perioperative Management

This is the standard care protocol for patients undergoing hip fracture surgery at the study hospital. It includes health education before surgery, regular vital sign monitoring, routine anticoagulation, and infection control management. Patients will receive standard perioperative management, including preoperative counseling, assistance with rehabilitation exercises, and monitoring of clinical symptoms and vital signs throughout the surgical and recovery process. There is no specific risk early warning scoring system in this group, and intervention is based on routine clinical monitoring.

Routine Perioperative Management

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This retrospective cohort study includes adult patients (aged ≥18 years) undergoing PFN fixation for hip fractures at Shiyan People's Hospital (January 2023-December 2023).

You may qualify if:

  • Diagnosed with unilateral intertrochanteric fracture of the femur confirmed by imaging.
  • Age 18 years or older.
  • Met the indications for surgical treatment and underwent fracture surgery in the study hospital.
  • Stable vital signs and clear consciousness postoperatively.

You may not qualify if:

  • Presence of hematologic diseases such as coagulation dysfunction.
  • Existing lower limb disability, invasive trauma, or other comorbid lesions.
  • History of mental disorders, cognitive impairment, or poor compliance with treatment protocols.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shiyan People's Hospital (People's Hospital Affiliated to Hubei Medical College)

Shiyan, China

Location

MeSH Terms

Conditions

Hip Fractures

Condition Hierarchy (Ancestors)

Femoral FracturesFractures, BoneWounds and InjuriesHip InjuriesLeg Injuries

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2025

First Posted

May 13, 2025

Study Start

January 1, 2023

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

May 13, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations